Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It … Read more
Market Cap & Net Worth: Ekso Bionics Holdings Inc (EKSO)
Ekso Bionics Holdings Inc (NASDAQ:EKSO) has a market capitalization of $38.09 Million ($38.09 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23892 globally and #8300 in its home market, demonstrating a -13.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ekso Bionics Holdings Inc's stock price $10.69 by its total outstanding shares 3563381 (3.56 Million).
Ekso Bionics Holdings Inc Market Cap History: 2015 to 2026
Ekso Bionics Holdings Inc's market capitalization history from 2015 to 2026. Data shows change from $381.64 Million to $38.09 Million (-20.83% CAGR).
Index Memberships
Ekso Bionics Holdings Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.00% | #638 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #2096 of 3165 |
Weight: Ekso Bionics Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Ekso Bionics Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ekso Bionics Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.41x
Ekso Bionics Holdings Inc's market cap is 2.41 times its annual revenue
169.88x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $212.73 Million | $14.22 Million | -$23.47 Million | 14.96x | N/A |
| 2017 | $113.85 Million | $7.35 Million | -$29.12 Million | 15.48x | N/A |
| 2018 | $66.28 Million | $11.33 Million | -$26.99 Million | 5.85x | N/A |
| 2019 | $20.90 Million | $13.92 Million | -$12.13 Million | 1.50x | N/A |
| 2020 | $21.84 Million | $8.88 Million | -$15.82 Million | 2.46x | N/A |
| 2021 | $9.44 Million | $11.25 Million | -$9.76 Million | 0.84x | N/A |
| 2022 | $4.24 Million | $12.91 Million | -$15.08 Million | 0.33x | N/A |
| 2023 | $8.91 Million | $18.28 Million | -$15.20 Million | 0.49x | N/A |
| 2024 | $2.17 Million | $17.93 Million | -$11.33 Million | 0.12x | N/A |
| 2025 | $30.79 Million | $12.80 Million | -$11.70 Million | 2.41x | N/A |
Competitor Companies of EKSO by Market Capitalization
Companies near Ekso Bionics Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Ekso Bionics Holdings Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
Ekso Bionics Holdings Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Ekso Bionics Holdings Inc's market cap moved from $381.64 Million to $ 38.09 Million, with a yearly change of -20.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $38.09 Million | +23.73% |
| 2025 | $30.79 Million | +1316.39% |
| 2024 | $2.17 Million | -75.60% |
| 2023 | $8.91 Million | +110.08% |
| 2022 | $4.24 Million | -55.09% |
| 2021 | $9.44 Million | -56.77% |
| 2020 | $21.84 Million | +4.52% |
| 2019 | $20.90 Million | -68.47% |
| 2018 | $66.28 Million | -41.78% |
| 2017 | $113.85 Million | -46.48% |
| 2016 | $212.73 Million | -44.26% |
| 2015 | $381.64 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Ekso Bionics Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.09 Million USD |
| MoneyControl | $38.09 Million USD |
| MarketWatch | $38.09 Million USD |
| marketcap.company | $38.09 Million USD |
| Reuters | $38.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.